The novel β2-selective proteasome inhibitor LU-102 decreases phosphorylation of I kappa B and induces highly synergistic cytotoxicity in combination with ibrutinib in multiple myeloma cells
Titel:
The novel β2-selective proteasome inhibitor LU-102 decreases phosphorylation of I kappa B and induces highly synergistic cytotoxicity in combination with ibrutinib in multiple myeloma cells
Auteur:
Kraus, Johannes Kraus, Marianne Liu, Nora Besse, Lenka Bader, Jürgen Geurink, Paul P. Bruin, Gerjan de Kisselev, Alexei F. Overkleeft, Herman Driessen, Christoph